Atogen

ATOGEN Co., Ltd. is a South Korean biotech company headquartered in Daejeon, specializing in microbiome-based drug development and health functional food ingredients. The company develops innovative therapeutics by modulating the composition and function of the human microbiome to treat diverse diseases including bacterial vaginosis, cancer, allergies, inflammatory conditions, and metabolic disorders. ATOGEN also researches and commercializes functional health ingredients for consumers, including probiotic products under the Dr. Myol and GoodLacToU brands. The company employs multi-omics analysis — genomics, transcriptomics, and metabolomics — to elucidate therapeutic mechanisms and operates a proprietary functional ingredient screening platform to identify efficacious strains.